Related Experiment Video

Updated: Feb 24, 2026

Generation of Discriminative Human Monoclonal Antibodies from Rare Antigen-specific B Cells Circulating in Blood
13:14

Generation of Discriminative Human Monoclonal Antibodies from Rare Antigen-specific B Cells Circulating in Blood

Published on: February 6, 2018

11.1K

Correction: Novel in vitro booster vaccination to rapidly generate antigen-specific human monoclonal antibodies

Irene Sanjuan Nandin, Carol Fong, Cecilia Deantonio

    The Journal of Experimental Medicine
    |August 23, 2017
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Generation of Murine Monoclonal Antibodies by Hybridoma Technology
    09:42

    Generation of Murine Monoclonal Antibodies by Hybridoma Technology

    Published on: January 2, 2017

    43.8K
    Generation of Monoclonal Antibodies Against Natural Products
    12:15

    Generation of Monoclonal Antibodies Against Natural Products

    Published on: April 6, 2019

    11.7K

    Related Experiment Videos

    Last Updated: Feb 24, 2026

    Generation of Discriminative Human Monoclonal Antibodies from Rare Antigen-specific B Cells Circulating in Blood
    13:14

    Generation of Discriminative Human Monoclonal Antibodies from Rare Antigen-specific B Cells Circulating in Blood

    Published on: February 6, 2018

    11.1K
    Generation of Murine Monoclonal Antibodies by Hybridoma Technology
    09:42

    Generation of Murine Monoclonal Antibodies by Hybridoma Technology

    Published on: January 2, 2017

    43.8K
    Generation of Monoclonal Antibodies Against Natural Products
    12:15

    Generation of Monoclonal Antibodies Against Natural Products

    Published on: April 6, 2019

    11.7K

    Related Concept Videos

    Hybridoma Technology01:31

    Hybridoma Technology

    18.0K
    Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
    Hybridoma Selection
    Commonly used fusion techniques — electroporation,...
    18.0K
    Vaccinations01:51

    Vaccinations

    52.2K
    Overview
    52.2K

    Articles linked to this work by shared authors, journal, and citation graph.

    A rationally designed neuraminidase immunogen elicits humoral responses to a conserved viral site.

    bioRxiv : the preprint server for biology·2026

    Intratumoral T cell activation kills tumors regardless of T cell specificity.

    Nature immunology·2026

    Concerted changes in the pediatric single-cell intestinal ecosystem before and after anti-TNF blockade.

    eLife·2026

    Follicular Lymphoma Transformation is Characterized by Cytokine-associated Remodeling of Stromal and Macrophage Compartments.

    Cancer discovery·2026

    Germinal center-independent memory B cells provide rapid protection from lethal influenza challenges.

    bioRxiv : the preprint server for biology·2026

    Ketogenic diet mediates intestinal tumorigenesis through lipids not ketones.

    Nature·2026

    Launching an independent research laboratory and scientific career: Tools for a rapidly changing landscape.

    The Journal of experimental medicine·2026

    The selected few: Mechanisms of HIV-1 reservoir persistence.

    The Journal of experimental medicine·2026

    Biallelic loss-of-function PTPN6 variants lead to inflammatory lung disease and hemolytic anemia.

    The Journal of experimental medicine·2026

    Natural microbiota-based mouse models: A platform to fast-track translation of fundamental discoveries into the clinic.

    The Journal of experimental medicine·2026

    The IKKε-GABPA axis regulates STING transcription to orchestrate antiviral immunity and inflammation.

    The Journal of experimental medicine·2026

    Helios is critical for Treg effector differentiation in adipose autoimmunity.

    The Journal of experimental medicine·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us